{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:51:56Z","timestamp":1776477116585,"version":"3.51.2"},"reference-count":20,"publisher":"S. Karger AG","issue":"3","license":[{"start":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T00:00:00Z","timestamp":1387584000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2013,12,21]],"date-time":"2013-12-21T00:00:00Z","timestamp":1387584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmologica"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Purpose:&lt;\/i&gt;&lt;\/b&gt; To assess a change in visual-related quality of life (QoL) in glaucoma patients after switching from preservative-containing medical therapy to preservative-free unit dose timolol\/dorzolamide fixed combination (TDFC UD). &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; Prospective, noninterventional, multicenter 8-week study. Primary outcome was a change in visual symptoms at week 8, as assessed by the Glaucoma Symptom Scale (GSS). &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; 80 patients completed the study. There was a clinically significant increase in the scores of all GSS-related categories at week 8 when compared to baseline (GSS symptom week 8: +21.15 \u00b1 37.9%, GSS function week 8: +10.3 \u00b1 31.6%, both p &lt; 0.001 vs. baseline). Comparison between patients taking only TDFC UD and patients taking TDFC UD plus concomitant medications did not detect differences in any GSS category (p &gt; 0.50 in all comparisons). &lt;b&gt;&lt;i&gt;Conclusions:&lt;\/i&gt;&lt;\/b&gt; Switching to TDFC UD significantly improved the self-reported QoL of glaucoma patients. This can be seen even in patients who are taking concomitant ocular treatments.<\/jats:p>","DOI":"10.1159\/000356468","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T10:06:38Z","timestamp":1387533998000},"page":"166-171","source":"Crossref","is-referenced-by-count":19,"title":["Improvement in Glaucoma Patient Quality of Life by Therapy Switch to Preservative-Free Timolol\/Dorzolamide Fixed Combination"],"prefix":"10.1159","volume":"231","author":[{"given":"Lu\u00eds","family":"Abeg\u00e3o Pinto","sequence":"first","affiliation":[]},{"given":"Evelien","family":"Vandewalle","sequence":"additional","affiliation":[]},{"given":"Laetitia","family":"Gerlier","sequence":"additional","affiliation":[]},{"given":"Ingeborg","family":"Stalmans","sequence":"additional","affiliation":[]},{"name":"The CosoptUD Switch Study Group","sequence":"additional","affiliation":[]}],"member":"127","published-online":{"date-parts":[[2013,12,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000220"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0b013e31815c5f4f"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.562340"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.05.033"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.11.060"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2010.0060"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-010-1397-7"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.116.7.861"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.4.418"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181c325b2"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF00184009"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.79.4.339"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2010.03.001"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90116-1"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2010.01907.x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S17876"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S10337"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.ijg.0000212252.72207.c2"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(98)91047-8"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1159\/000334791"}],"container-title":["Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/356468","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/356468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:18:37Z","timestamp":1745432317000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000356468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,21]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,1]]},"published-print":{"date-parts":[[2014,3,13]]}},"URL":"https:\/\/doi.org\/10.1159\/000356468","archive":["Portico"],"relation":{},"ISSN":["0030-3755","1423-0267"],"issn-type":[{"value":"0030-3755","type":"print"},{"value":"1423-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,21]]}}}